First author [ref.] | Active/ control n | Inclusion criteria | Oxygen treatment | Exercise training | Main outcome parameters | Results active/placebo |
Rooyackers [23] | 12/12 | PO2 >8.5 kPa, nocturnal SO2 >90%, SO2,max exercise <90%, ΔPA–a,O2,rest max exercise >2 kPa | 4 L·min−1 | Strength + endurance (cycling), SO2 >90%: 10 weeks, 5 days·week−1, 80 min·day−1 | CWRT, 6MWD, CRQ | ns |
Fichter [24] | 5/5 | 35% | Cycling: 4 weeks, 5 days·week−1 | Wmax,cycle ergometry | ns | |
Garrod [25] | 11/11 | FEV1 <40%, SO2,exercise <90% and ΔSO2 >4% | 4 L·min−1 | Cycling/walking: 6 weeks, 3 days·week−1, 1 h·day−1 | ISWT, CRQ | ns |
Wadell [26] | 10/10 | SO2,6MWD <92%, PO2 >7.8 kPa | 5 L·min−1 | Walking, SO2 >90%: 8 weeks, 3 days·week−1, 30 min·day−1 | 6MWD | ns |
Emtner [27] | 14/15 | FEV1 <50%, PO2 >7.3 kPa, SO2,CWRT >88% | 3 L·min−1 | Cycling: 7 weeks, 3 days·week−1, 45 min·day−1 | CWRT | 14.5/10.0 min* |
Scorsone [28]# | 7/9 | 40% | Cycling; 8 weeks, 3 days·week−1, 40 min·day−1 | Wmax,cycle ergometry, CWRT | ns |
PO2: partial pressure of oxygen; SO2: oxygen saturation; Δ: change; PA–a,O2: alveolar–arterial oxygen gradient; FEV1: forced expiratory volume in 1 s; 6MWD: 6-min walk distance; CWRT: constant work rate test; CRQ: Chronic Respiratory Questionnaire; Wmax: maximum work; ISWT: Incremental Shuttle Walk Test; ns: not significant. #: three-arm study: 40% O2, heliox (He 60%/O2 40%) and air, presented results 40% O2 versus air. *: p<0.05.